Systemic Sclerosis
Systemic sclerosis, or scleroderma, is a rare autoimmune disease characterized by the hardening and tightening of the skin and connective tissues, which can also affect internal organs like the lungs.
Systemic Sclerosis: Nintedanib and Tocilizumab Study
We are testing a combination of nintedanib and tocilizumab for patients with systemic sclerosis and interstitial lung disease. The goal is to see if this new treatment is more effective than standard therapies.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Systemic Sclerosis with Interstitial Lung Disease
Systemic sclerosis with interstitial lung disease (ILD) is a complication of scleroderma that affects lung tissue, leading to breathing difficulties and reduced lung function.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 74 years old?
- Do you have systemic sclerosis (a disease that affects the skin and internal organs)?
- Are you currently pregnant or breastfeeding?
- Are you taking oral corticosteroids like prednisone at a dose of 10 mg or less per day?
- Have you had major surgery in the past 8 weeks?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Agarf
Avtozma
Gevesla
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Uniwersytecki Szpital Kliniczny Nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Łodzi
Klinika Pneumonologii
Łódź, Poland
Uniwersytet Medyczny W Lodzi
Klinika Reumatologii
Łódź, Poland
Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher
Centrum Wsparcia Badań Klinicznych
Ochota, Poland
Sponsor: Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.